Xeris Biopharma Holdings, Inc. (XERS) Revenues USD 2021 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Revenues history and growth rate from 2021 to 2022.
  • Xeris Biopharma Holdings, Inc. Revenues for the quarter ending March 31, 2022 was $22.1 M, a 169% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Revenues for 2021 was $49.6 M, a 143% increase from 2020.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $22.1 M +$13.9 M +169% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-11
Q1 2021 $8.2 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.